Bessemer Group Inc Bio Techne Corp Transaction History

Bessemer Group Inc

  • $61.6 Billion
  • Q2 2025

A detailed history of Bessemer Group Inc transactions in Bio Techne Corp stock. As of the latest transaction made, Bessemer Group Inc holds 11,950 shares of TECH stock, worth $736,120. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,950
Previous 19,748 39.49%
Holding current value
$736,120
Previous $1.16 Million 46.93%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 01, 2025
SELL
$46.66 - $58.38 $363,854 - $455,247
-7,798 Reduced 39.49%
11,950 $614,000
Q1 2025

Apr 23, 2025
SELL
$58.47 - $78.75 $3.59 Million - $4.83 Million
-61,323 Reduced 75.64%
19,748 $1.16 Million
Q4 2024

Feb 13, 2025
SELL
$66.37 - $78.17 $34,379 - $40,492
-518 Reduced 0.63%
81,071 $5.84 Million
Q3 2024

Nov 12, 2024
BUY
$70.96 - $82.35 $2.97 Million - $3.45 Million
41,860 Added 105.36%
81,589 $6.52 Million
Q2 2024

Aug 13, 2024
SELL
$62.12 - $84.15 $65,039 - $88,105
-1,047 Reduced 2.57%
39,729 $2.85 Million
Q1 2024

May 13, 2024
BUY
$65.98 - $77.09 $1.45 Million - $1.7 Million
22,037 Added 117.6%
40,776 $2.87 Million
Q4 2023

Feb 09, 2024
SELL
$52.83 - $78.22 $48,286 - $71,493
-914 Reduced 4.65%
18,739 $1.45 Million
Q3 2023

Nov 13, 2023
BUY
$67.52 - $89.42 $43,955 - $58,212
651 Added 3.43%
19,653 $1.34 Million
Q2 2023

Aug 10, 2023
SELL
$73.76 - $85.98 $225,115 - $262,410
-3,052 Reduced 13.84%
19,002 $1.55 Million
Q1 2023

May 10, 2023
SELL
$71.62 - $86.62 $132,711 - $160,506
-1,853 Reduced 7.75%
22,054 $1.64 Million
Q4 2022

Feb 13, 2023
BUY
$80.67 - $352.29 $1.52 Million - $6.64 Million
18,844 Added 372.19%
23,907 $1.98 Million
Q3 2022

Nov 09, 2022
BUY
$282.54 - $391.85 $196,647 - $272,727
696 Added 15.94%
5,063 $1.44 Million
Q2 2022

Aug 10, 2022
BUY
$322.67 - $449.65 $296,856 - $413,678
920 Added 26.69%
4,367 $1.51 Million
Q1 2022

May 12, 2022
BUY
$353.85 - $487.79 $491,497 - $677,540
1,389 Added 67.49%
3,447 $1.49 Million
Q4 2021

Jan 27, 2022
BUY
$456.15 - $525.06 $411,903 - $474,129
903 Added 78.18%
2,058 $1.07 Million
Q3 2021

Nov 12, 2021
BUY
$444.87 - $538.88 $21,353 - $25,866
48 Added 4.34%
1,155 $559,000
Q2 2021

Aug 06, 2021
BUY
$387.35 - $450.26 $13,169 - $15,308
34 Added 3.17%
1,107 $498,000
Q1 2021

May 13, 2021
SELL
$314.62 - $411.0 $215,200 - $281,124
-684 Reduced 38.93%
1,073 $409,000
Q4 2020

Feb 09, 2021
BUY
$246.9 - $321.87 $4,938 - $6,437
20 Added 1.15%
1,757 $558,000
Q3 2020

Nov 12, 2020
SELL
$232.22 - $282.96 $811,376 - $988,662
-3,494 Reduced 66.79%
1,737 $430,000
Q2 2020

Aug 05, 2020
BUY
$185.43 - $279.56 $868,183 - $1.31 Million
4,682 Added 852.82%
5,231 $1.38 Million
Q2 2019

Jul 19, 2019
BUY
$188.72 - $215.43 $95,681 - $109,223
507 Added 1207.14%
549 $114,000
Q1 2019

May 13, 2019
SELL
$136.09 - $200.44 $165,621 - $243,935
-1,217 Reduced 96.66%
42 $8,000
Q4 2018

Feb 12, 2019
BUY
$132.75 - $203.8 $4,911 - $7,540
37 Added 3.03%
1,259 $182,000
Q3 2018

Nov 06, 2018
SELL
$147.44 - $204.11 $48,360 - $66,948
-328 Reduced 21.16%
1,222 $249,000
Q2 2018

Jul 25, 2018
SELL
$144.9 - $165.58 $325,735 - $372,223
-2,248 Reduced 59.19%
1,550 $230,000
Q1 2018

May 10, 2018
SELL
$131.46 - $151.04 $474,307 - $544,952
-3,608 Reduced 48.72%
3,798 $574,000
Q4 2017

Jan 30, 2018
BUY
$121.17 - $134.75 $12,117 - $13,475
100 Added 1.37%
7,406 $959,000
Q3 2017

Nov 03, 2017
BUY
$113.59 - $123.78 $829,888 - $904,336
7,306
7,306 $882,000

Others Institutions Holding TECH

# of Institutions
611
Shares Held
161M
Call Options Held
225K
Put Options Held
80.8K
View Full List

About BIO-TECHNE Corp

TECH Quotes by TradingView
  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.42B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Bessemer Group Inc Portfolio

Follow Bessemer Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email